checkAd
    Startseite > Aktien > Aquestive Therapeutics > Nachrichten
    Aquestive Therapeutics Aktie
    2,7600
     
    USD
    +0,36 %
    +0,0100 USD
    Letzter Kurs 10.06.24 Nasdaq
    2,7600
     
    USD
    200 STK
    Geldkurs 10.06.24
    2,7700
     
    USD
    1.100 STK
    Briefkurs 10.06.24
    ISIN: US03843E1047 · WKN: A2JQ4G · SYM: AQST · USA

    Neueste Nachrichten

    Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
    03.06.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics to Present Anaphylm (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference
    28.05.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
    09.05.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    07.05.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm (epinephrine) Sublingual Film
    29.04.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8: 00 a.m. ET
    25.04.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics to Present Crossover Study Data for Libervant (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
    12.04.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
    01.04.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
    25.03.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
    20.03.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
    19.03.24 · globenewswire · Aquestive Therapeutics
    Aquestive Therapeutics Announces Pivotal Study for Anaphylm (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting
    14.03.24 · globenewswire · Aquestive Therapeutics